Our Clinical Peptide Solutions for You!

Focused on immunotherapy and cell therapy, ISO PLUS peptides meet higher regulatory standards than those required for research use. 

From Research to Clinical Development 

ISO PLUS peptides are designed to support projects from the early research stage all the way through translational and clinical stages. For customers planning cell- and immuno-therapeutic development, JPT also offers clinical-grade peptide manufacturing under strict quality standards. 

While ISO PLUS peptides provide exceptional purity for advanced research, JPT’s clinical-grade peptides meet the stringent quality and regulatory requirements required for therapeutic development:

Key advantages include: 

• High purity peptide synthesis 
• Seamless transition from research-grade to clinical-grade production 
• Scalable 
• Expertise in complex and modified peptide sequences

Why Choose JPT? 

With decades of experience in peptide synthesis, JPT supports researchers and biotech innovators worldwide with robust peptide solutions for discovery, preclinical, and clinical programs. If you are planning a project that requires clinical-grade peptides or scalable peptide manufacturing, our team would be happy to discuss your requirements.